BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36198994)

  • 1. Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial.
    Mollazadeh-Narestan Z; Yavarikia P; Homayouni-Rad A; Samadi Kafil H; Mohammad-Alizadeh-Charandabi S; Gholizadeh P; Mirghafourvand M
    Probiotics Antimicrob Proteins; 2023 Oct; 15(5):1436-1446. PubMed ID: 36198994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
    Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
    Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Recurrence of Vulvovaginal Candidiasis in Patients Undergoing Prophylactic Treatment with Probiotic and Placebo During the 6 Months.
    Davar R; Nokhostin F; Eftekhar M; Sekhavat L; Bashiri Zadeh M; Shamsi F
    Probiotics Antimicrob Proteins; 2016 Sep; 8(3):130-3. PubMed ID: 27206514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
    Ray A; Ray S; George AT; Swaminathan N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F; Del Piano M; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial.
    Wang X; Chen L; Ruan H; Xiong Z; Wang W; Qiu J; Song W; Zhang C; Xue F; Qin T; Zhang B; An R; Luo X; Wang W; Zhang S; Cai Y; Kang J; Deng H; Fan S; Cui M; Wang S; Luo X; Su Z; Shu J; Wang Q; Wang F; Bai J; Liao Q
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0077823. PubMed ID: 38095426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women.
    Vahedpoor Z; Abastabar M; Sehat M; Talebian P; Felfelian Fini T; Dastanpour Z; Haghani I; Chelongarian R; Nazeri M
    Curr Med Mycol; 2021 Sep; 7(3):36-43. PubMed ID: 35528620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
    Seidman LS; Skokos CK
    Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
    Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis.
    O-Prasertsawat P; Bourlert A
    Sex Transm Dis; 1995; 22(4):228-30. PubMed ID: 7482105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved treatment of vulvovaginal candidiasis with Clotrimazole plus probiotic Lacidophilin Vaginal Capsules: A prospective, real-world study.
    Zeng X; An R; Li H; Zhang Y
    Medicine (Baltimore); 2023 Jan; 102(1):e32664. PubMed ID: 36607885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.